Neose Technologies News (NASDAQ:NTEC)
| Latest Neose Technologies News Headlines | | Date | Time | Source | | | 01/25/2006 | 11:53AM | PRNUS | Neose Receives Notice of Allowance for U.S. Patent Broadly Covering GlycoPEGylation(TM) of Peptides
Provides Validation of Novel GlycoPEGylation(TM) Technology
HORSHAM, Pa., Jan. 25 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application related to its GlycoPEGylation(TM) technology... More...>> |
| 01/04/2006 | 1:33PM | PRNUS | Neose Technologies to Present at JPMorgan Healthcare Conference
HORSHAM, Pa., Jan. 4 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) announced today that it will present at the JPMorgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco from January 9-12, 2006. C. Boyd Clarke, Neose's chief executive officer and chairman, will present... More...>> |
| 01/03/2006 | 4:19PM | PRNUS | Neose Receives Clearance to Initiate Human Clinical Trials for NE-180 (GlycoPEGylated EPO) in Western Europe
HORSHAM, Pa., Jan. 3 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today announced that it has been notified by the regulatory authority in a Western European jurisdiction that it can commence human clinical trials for NE-180, the company's long-acting, GlycoPEGylated erythropoietin for the treatment... More...>> |
| 12/22/2005 | 6:07PM | PRNUS | Neose Provides Update on NE-180 Program
HORSHAM, Pa., Dec. 22 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today provided an update on its NE-180 (GlycoPEG-EPO) program. The Company has been pursuing parallel efforts in the United States and Europe to move its NE-180 candidate into clinical trials. As part of its NE-180 development strategy... More...>> |
| 12/15/2005 | 4:01PM | PRNUS | Neose and Novo Nordisk Expand Agreement
HORSHAM, Pa., Dec. 15 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today announced the expansion of its research and development activities under its license agreement with Novo Nordisk A/S (NYSE:NVO) entered into in November 2003 to use Neose's GlycoPEGylation(TM) technology to develop a next-generation... More...>> |
| 11/21/2005 | 4:01PM | PRNUS | Neose Receives Milestone Payment From Novo Nordisk on Second Protein
HORSHAM, Pa., Nov. 21 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today announced that it received a milestone payment from Novo Nordisk A/S (NYSE:NVO) under the license agreements entered into in November 2003 to use Neose's GlycoPEGylation(TM) technology to develop next-generation versions of... More...>> |
| 11/02/2005 | 4:01PM | PRNUS | Neose Technologies Reports Third Quarter Financial Results
August Restructuring Leads to Non-Cash Charges of $13.2 Million
HORSHAM, Pa., Nov. 2 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today announced financial results for the third quarter and nine months ended September 30, 2005.
For the quarter ended September 30, 2005, the Company reported a net... More...>> |
| 11/01/2005 | 3:11PM | PRNUS | Neose Technologies to Present at Rodman & Renshaw Techvest Healthcare Conference
HORSHAM, Pa., Nov. 1 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) announced today that it will present at the Rodman & Renshaw Techvest Healthcare Conference being held at the New York Palace Hotel in New York from November 7-9, 2005. C. Boyd Clarke, Neose's chief executive officer and chairman... More...>> |
| 10/26/2005 | 12:49PM | PRNUS | Neose to Host Third Quarter 2005 Conference Call
HORSHAM, Pa., Oct. 26 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today announced that it will release financial results for the third quarter of 2005 on Wednesday, November 2, 2005, after the U.S. financial markets close. The company will host a conference call at 5:00 p.m. (ET) the same day to... More...>> |
| 10/12/2005 | 1:26PM | PRNUS | Neose Technologies to Present at BIO Investor Forum
HORSHAM, Pa., Oct. 12 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) announced today that it will present at the Biotechnology Industry Organization Investor Forum being held at the Palace Hotel in San Francisco from October 18-20, 2005. C. Boyd Clarke, Neose's chief executive officer and chairman... More...>> |
| 10/10/2005 | 8:30AM | PRNUS | Neose Technologies Names George J. Vergis, Ph.D. President and Chief Operating Officer
Announces Senior Management Changes
HORSHAM, Pa., Oct. 10 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today announced changes to its senior management team, including the naming of George J. Vergis, Ph.D., as president and chief operating officer and the retirement effective October 31, 2005 of... More...>> |
| 09/19/2005 | 5:32PM | PRNUS | Neose Technologies to Present at UBS Global Life Sciences Conference
HORSHAM, Pa., Sept. 19 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) announced today that it will present at the UBS Global Life Sciences Conference being held at the Grand Hyatt in New York City from September 26-29, 2005. C. Boyd Clarke, Neose's president, chief executive officer and chairman... More...>> |
| 08/04/2005 | 4:05PM | PRNUS | Neose Technologies Announces Restructuring Of Operations; Provides Update On Corporate Objectives
HORSHAM, Pa., Aug. 4 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today announced that it has implemented a restructuring of operations and updated its key operational objectives.
The restructuring has been implemented to enable an enhanced focus by the Company on next-generation proteins, to allow... More...>> |
| 08/04/2005 | 4:04PM | PRNUS | Neose Technologies Reports Second Quarter Financial Results
HORSHAM, Pa., Aug. 4 /PRNewswire-FirstCall/ -- Neose Technologies, Inc. (NASDAQ:NTEC) today announced financial results for the second quarter and six months ended June 30, 2005.
For the quarter ended June 30, 2005, the Company reported a net loss of $10,285,000, or $0.31 per basic and diluted share, compared to a... More...>> |
| 07/28/2005 | 4:00PM | PRNUS | Neose to Host Second Quarter 2005 Conference Call
Neose to Host Second Quarter 2005 Conference Call
HORSHAM, Pa., July 28 /PRNewswire-FirstCall/ -- Neose Technologies, Inc.
(NASDAQ:NTEC) today announced that it will release financial results for the
second quarter of 2005 on Thursday, August 4, 2005, after the U.S. financial
markets close. The company will host a... More...>> |
| 07/19/2005 | 8:39PM | PRNUS | Neose Provides Update on IND Review for NE-180
Neose Provides Update on IND Review for NE-180
HORSHAM, Pa., July 19 /PRNewswire-FirstCall/ -- Neose Technologies, Inc.
(NASDAQ:NTEC) announced that the U.S. Food and Drug Administration (FDA) orally
advised the Company today that it has placed the Company's proposed Phase I
clinical trial for NE-180 on hold. The Company... More...>> |
| 06/23/2005 | 4:38PM | PRNUS | Neose Files IND for NE-180 for the Treatment of Anemia
Neose Files IND for NE-180 for the Treatment of Anemia
HORSHAM, Pa., June 23 /PRNewswire-FirstCall/ -- Neose Technologies, Inc.
(NASDAQ:NTEC) today announced that it has submitted an investigational new drug
application (IND) to the U.S. Food and Drug Administration (FDA) for NE- 180.
NE-180 is the company's long-acting... More...>> |
| 05/17/2005 | 3:04PM | PRNUS | Neose Technologies to Present at UBS Global Pharmaceuticals Conference
Neose Technologies to Present at UBS Global Pharmaceuticals
Conference
HORSHAM, Pa., May 17 /PRNewswire-FirstCall/ -- Neose Technologies, Inc.
(NASDAQ:NTEC) announced today that it will present at the UBS Global
Pharmaceuticals Conference being held at the Grand Hyatt in New York City from
May 23-24, 2005. C. Boyd... More...>> |
| 05/13/2005 | 10:27AM | PRNUS | Neose Receives Milestone Payment From Novo Nordisk
Neose Receives Milestone Payment From Novo Nordisk
HORSHAM, Pa., May 13 /PRNewswire-FirstCall/ -- Neose Technologies, Inc.
(NASDAQ:NTEC) today announced that it received a scheduled milestone payment
from Novo Nordisk A/S (NYSE:NVO) under the license agreement entered into in
November 2003 to use Neose's GlycoPEGylation(TM... More...>> |
| 05/03/2005 | 4:01PM | PRNUS | Neose Technologies Reports First Quarter Financial Results
Neose Technologies Reports First Quarter Financial Results
HORSHAM, Pa., May 3 /PRNewswire-FirstCall/ -- Neose Technologies, Inc.
(NASDAQ:NTEC) today announced financial results for the quarter ended March 31,
2005.
For the quarter ended March 31, 2005, the Company reported a net loss of
$11,267,000, or $0.40 per basic... More...>> |
|
|
|